Results 161 to 170 of about 1,550,218 (322)
Coupled fixed point theorems in G b -metric space satisfying some rational contractive conditions. [PDF]
Khomdram B, Rohen Y, Singh TC.
europepmc +1 more source
Some coupled fixed point theorems in partially ordered S-metric spaces [PDF]
Vishal Gupta, Raman Deep
openalex +1 more source
Methods to improve antibody–drug conjugate (ADC) treatment durability in cancer therapy are needed. We utilized ADCs and immune‐stimulating antibody conjugates (ISACs), which are made from two non‐competitive antibodies, to enhance the entry of toxic payloads into cancer cells and deliver immunostimulatory agents into immune cells.
Tiexin Wang +3 more
wiley +1 more source
Common coupled fixed point theorems satisfying rational type contractive conditions in b-metric spaces. [PDF]
Sarwar M, Hussain S, Kumari PS.
europepmc +1 more source
FG-coupled Fixed Point Theorems for Contractive Type Mappings in Partially Ordered Metric Spaces [PDF]
Deepa Karichery, Shaini Pulickakunnel
openalex +1 more source
Etoposide induces DNA damage, activating p53‐dependent apoptosis via caspase‐3/7, which cleaves PARP1. Dammarenediol II enhances this apoptotic pathway by suppressing O‐GlcNAc transferase activity, further decreasing O‐GlcNAcylation. The reduction in O‐GlcNAc levels boosts p53‐driven apoptosis and influences the Akt/GSK3β/mTOR signaling pathway ...
Jaehoon Lee +8 more
wiley +1 more source
Common Coupled Fixed Point Theorems for Two Hybrid Pairs of Mappings under φ-ψ Contraction. [PDF]
Deshpande B, Handa A.
europepmc +1 more source
Symmetrical Hybrid Coupled Fuzzy Fixed-Point Results on Closed Ball in Fuzzy Metric Space with Applications [PDF]
Tahair Rasham +4 more
openalex +1 more source
Tumor mutational burden as a determinant of metastatic dissemination patterns
This study performed a comprehensive analysis of genomic data to elucidate whether metastasis in certain organs share genetic characteristics regardless of cancer type. No robust mutational patterns were identified across different metastatic locations and cancer types.
Eduardo Candeal +4 more
wiley +1 more source
Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat +8 more
wiley +1 more source

